THE EFFECT OF CANGRELOR VERSUS TICAGRELOR ON PLATELET ACTIVITY, CORONARY MICRO-CIRCULAR FUNCTION AND INFARCT SIZE IN PATIENTS SUFFERING ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION TREATED WITH PRIMARY PERCUTANEOUS CORONARY INTERVENTION: A RANDOMIZED CONTROLLED TRIAL

Salahaddin Ubaid,Thomas J. Ford,Colin Berry,Saib Khogali,Benjamin Wrigley,Shahzad Munir,Joe Martins,Rumi Jaumdally,Vincent Amoah,Nazish Khan,Townend Jon,Elisa McAlindon,James Cotton

THE EFFECT OF CANGRELOR VERSUS TICAGRELOR ON PLATELET ACTIVITY, CORONARY MICRO-CIRCULAR FUNCTION AND INFARCT SIZE IN PATIENTS SUFFERING ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION TREATED WITH PRIMARY PERCUTANEOUS CORONARY INTERVENTION: A RANDOMIZED CONTROLLED TRIAL

2018

Salahaddin Ubaid
Thomas J. Ford
Colin Berry
Saib Khogali
Benjamin Wrigley
Shahzad Munir
Joe Martins
Rumi Jaumdally
Vincent Amoah
Nazish Khan
Townend Jon
Elisa McAlindon
James Cotton

Despite advances in ST-segment elevation myocardial infarction (STEMI) treatment, a sizeable minority of patients suffer poor outcomes even when treated with timely primary percutaneous coronary intervention (PPCI). More potent P2Y12 inhibition improves clinical outcomes, however oral agents have

Keywords:

Percutaneous coronary intervention
Randomized controlled trial
Cangrelor
Myocardial infarction
Diabetes mellitus
Ticagrelor
Cardiology
Internal medicine
Platelet
P2Y12
Medicine
platelet activation

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations